ASND (ASND) Stock Price & Analysis
ASND (ASND) rose 0.00% to USD 253.86 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
ASND last closed at USD 253.86; the session ranged USD 251.99–258.86 on volume of 360,735 shares. Market capitalization is —, with a 52-week range of USD 160.86–282.15 (NMS). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 253.86 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 253.86 |
| Open | USD 253.86 |
| Day Range | USD 251.99 – 258.86 |
| 52-Week Range | USD 160.86 – 282.15 |
| Volume | 360,735 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ASND)
Nexqual's technical model rates ASND "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.67 (neutral) |
| vs SMA50 | Above (USD 243.62) |
| MACD | 2.97 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARGX | argenx SE | USD 918.22 | ▲ 7.81% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 26.9 | ▼ 2.69% |
| KRYS | Krystal Biotech, Inc. | USD 335.19 | ▼ 0.48% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 544.51 | ▲ 1.28% |
| BBIO | BridgeBio Pharma, Inc. | USD 84.02 | ▲ 1.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.